Erlotinib vs Oseltamivir
Erlotinib vs Oseltamivir: Overview
This comparison examines the pharmacological differences between Erlotinib and Oseltamivir.
Mechanism of Action
Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.
Oseltamivir: Neuraminidase inhibitor preventing viral release from host cells.
Pharmacokinetics
Half-life: Erlotinib β 36 hours; Oseltamivir β 6-10 hours.
Chemical Properties
Molecular Formula: Erlotinib β C22H23N3O4; Oseltamivir β C16H28N2O4.
Molecular Weight: Erlotinib β 393.4380 g/mol; Oseltamivir β 312.4050 g/mol.
Type: Erlotinib β Small molecule; Oseltamivir β Small molecule.